LU80078A1 - Procede de preparation de pyrazoles substitues en position 4 et leur utilisation therapeutique - Google Patents

Procede de preparation de pyrazoles substitues en position 4 et leur utilisation therapeutique

Info

Publication number
LU80078A1
LU80078A1 LU80078A LU80078A LU80078A1 LU 80078 A1 LU80078 A1 LU 80078A1 LU 80078 A LU80078 A LU 80078A LU 80078 A LU80078 A LU 80078A LU 80078 A1 LU80078 A1 LU 80078A1
Authority
LU
Luxembourg
Prior art keywords
therapeutic use
preparing pyrazoles
pyrazoles substituted
substituted
preparing
Prior art date
Application number
LU80078A
Other languages
English (en)
French (fr)
Original Assignee
Sterling Drug Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterling Drug Inc filed Critical Sterling Drug Inc
Publication of LU80078A1 publication Critical patent/LU80078A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/225—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
LU80078A 1977-08-05 1978-08-04 Procede de preparation de pyrazoles substitues en position 4 et leur utilisation therapeutique LU80078A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/822,246 US4171365A (en) 1977-08-05 1977-08-05 Antiviral aryloxyalkylpyrazoles

Publications (1)

Publication Number Publication Date
LU80078A1 true LU80078A1 (fr) 1979-05-15

Family

ID=25235560

Family Applications (1)

Application Number Title Priority Date Filing Date
LU80078A LU80078A1 (fr) 1977-08-05 1978-08-04 Procede de preparation de pyrazoles substitues en position 4 et leur utilisation therapeutique

Country Status (16)

Country Link
US (1) US4171365A (da)
JP (1) JPS5430175A (da)
AU (1) AU515984B2 (da)
BE (1) BE869509A (da)
CA (1) CA1112244A (da)
CH (1) CH635080A5 (da)
DE (1) DE2834322A1 (da)
DK (1) DK345778A (da)
FR (2) FR2409988A1 (da)
GB (1) GB2003859B (da)
IE (1) IE47139B1 (da)
IT (1) IT1099591B (da)
LU (1) LU80078A1 (da)
NL (1) NL7808179A (da)
NZ (1) NZ187960A (da)
SE (1) SE7808418L (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4372976A (en) * 1981-08-07 1983-02-08 Sterling Drug Inc. Novel aryl-aliphatic ketone and its use as an antiviral agent
ZA846525B (en) * 1983-08-29 1985-04-24 Sterling Drug Inc (substituted)phenyl-aliphatic-isoxazoles useful as antiviral agents and preparation thereof
GB8807275D0 (en) * 1988-03-26 1988-04-27 Synphar Lab Inc Chemical compounds
US6514936B1 (en) 1988-09-01 2003-02-04 Bayer Corporation Antiviral methods using human rhinovirus receptor (ICAM-1)
US6143298A (en) * 1988-09-01 2000-11-07 Bayer Corporation Soluble truncated forms of ICAM-1
EP0362531B1 (en) 1988-09-01 1999-11-10 Bayer Corporation A human rhinovirus receptor protein that inhibits virus infectivity
US6051231A (en) * 1988-09-01 2000-04-18 Bayer Corporation Antiviral methods and prepations
ZA896668B (en) * 1988-09-01 1990-06-27 Molecular Therapeutics Inc A human rhinovirus receptor protein that inhibits virus infectivity
DE4012409A1 (de) * 1990-04-19 1991-10-24 Basf Ag Hydrochinondiether, ihre herstellung und ihre verwendung
ATE184049T1 (de) * 1990-07-20 1999-09-15 Bayer Ag Multimere formen des menschlichen rhinovirus- rezeptorproteins
US5686582A (en) * 1990-07-20 1997-11-11 Bayer Corporation Multimeric forms of human rhinovirus receptor protein
US5686581A (en) * 1990-07-20 1997-11-11 Bayer Corporation Multimeric form of human rhinovirus receptor protein
JP2004123732A (ja) * 2002-09-10 2004-04-22 Takeda Chem Ind Ltd ５員複素環化合物
WO2004024705A1 (ja) * 2002-09-10 2004-03-25 Takeda Pharmaceutical Company Limited ５員複素環化合物
US9169214B2 (en) 2012-12-21 2015-10-27 The Board Of Trustees Of The Leland Stanford Junior University Compounds and compositions that bind and stabilize transthyretin and their use for inhibiting transthyretin amyloidosis and protein-protein interactions
US20160045609A1 (en) * 2014-08-14 2016-02-18 Mamoun M. Alhamadsheh Conjugation of pharmaceutically active agents with transthyretin ligands through adjustable linkers to increase serum half-life
EP3582773A4 (en) 2017-02-17 2021-03-10 Eidos Therapeutics, Inc. PROCESS FOR THE MANUFACTURING OF AG-10, ITS INTERMEDIATES AND SALTS THEREOF
WO2019183463A1 (en) 2018-03-23 2019-09-26 Eidos Therapeutics, Inc. Methods of treating ttr amyloidosis using ag10
LT3836920T (lt) 2018-08-17 2026-01-26 Eidos Therapeutics, Inc. Ag10 farmacinės formos

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3190888A (en) * 1963-08-22 1965-06-22 American Home Prod Aryloxyalkylpyrazole
US3326933A (en) * 1964-03-02 1967-06-20 Upjohn Co 3-alkyl-5-phenoxy-methylpyrazoles
US3746768A (en) * 1970-10-02 1973-07-17 Scm Corp Substituted phenyl ethers and thioethers as insect repellents
US4031246A (en) * 1973-07-23 1977-06-21 Sterling Drug Inc. Aryloxyalkyl diketones

Also Published As

Publication number Publication date
FR2409988A1 (fr) 1979-06-22
SE7808418L (sv) 1979-02-06
BE869509A (fr) 1979-02-05
FR2409989B1 (da) 1981-10-16
CH635080A5 (fr) 1983-03-15
IT1099591B (it) 1985-09-18
FR2409988B1 (da) 1982-07-16
JPS5430175A (en) 1979-03-06
GB2003859B (en) 1982-03-03
AU515984B2 (en) 1981-05-14
IE781479L (en) 1979-02-05
AU3839778A (en) 1980-01-31
IE47139B1 (en) 1983-12-28
US4171365A (en) 1979-10-16
GB2003859A (en) 1979-03-21
NL7808179A (nl) 1979-02-07
IT7826458A0 (it) 1978-08-03
CA1112244A (en) 1981-11-10
DE2834322A1 (de) 1979-02-15
DK345778A (da) 1979-02-06
FR2409989A1 (fr) 1979-06-22
NZ187960A (en) 1980-12-19

Similar Documents

Publication Publication Date Title
MY8800108A (en) Improvements in or relating to humidifying apparatus
GB2002213B (en) Apparatus in or relating to ploughs
LU81439A1 (fr) Octahydro-pyrazolo(3,4-g)quinoleines et leur utilisation therapeutique
LU80081A1 (fr) Nouvelles hydroxymethyl-5 oxazolidinones-2,leur procede de preparation et leur application therapeutique
BE865137A (fr) Composes de 5-trifluoromethylpyridine substitues en position 2 et leur procede de preparation
BE869509A (fr) Pyrazoles substitues en position 4, leur preparation et leur utilisation therapeutique
BE866841A (fr) Procede de preparation d'imidazoazines et -diazines substituees et leur utilisation
FR2290204A1 (fr) Nouveaux (hydroxy-1 (amino substitue)-2 alkyl)-5 carbostyriles substitues en position 8, nouveaux dihydro-3,4 carbostyriles correspondants, leur procede de preparation, et leur utilisation therapeutique
MY8300173A (en) Improvements in or relating to medical radiographic apparatus
BE864739A (fr) Polypeptides et procede pour leur preparation
BE865805A (fr) 1,2,3-thiadiazol-3-in-5-ylidene-urees, leur procede de preparation et leur utilisation
FR2349587A1 (fr) 1,3-dihydro-heteroarylspiro(isobenzofurannes), leur procede de preparation et leur application therapeutique
DE2860981D1 (en) 4-hydroxy-2-benzimidazolinone derivatives, process for their preparation and their use in medicaments
LU79805A1 (fr) Procede de preparation de la mercaptoacetylamidobenzoylglycine et procede therapeutique de mucolyse
BE854812A (fr) Benzenesulfonylurees, leur procede de preparation et leur application therapeutique
BE878127A (fr) Amides 1,2,3-triazolecarboxyliques, leur procede de preparation et leur utilisation
DE2860659D1 (en) 1,4-dihydropyridazines, process for their preparation and their use in pharmaceuticals
FR2348910A1 (fr) Procede de preparation d'aralkylarylamines et d'alkylarylamines
PT68267A (fr) Procede de preparation de derives d'oxadiazole-1,2,4 et leur application en therapeutique
BE870687A (fr) Nouvelles monoalkylanilines substituees en position 4 utiles comme medicaments et procedes pour leur preparation
DE2860469D1 (en) 4"-ureido-oleandomycin derivatives, process for their preparation and their use in pharmaceutical compositions
LU81440A1 (fr) Octahydro-2h-pyrrolo(3,4-g)quinoleines et leur utilisation therapeutique
LU78873A1 (fr) Alkylthio-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1h-3-benzazepines,leur procede de preparation et application en therapeutique
DE2965499D1 (en) Apparatus for use in physiological monitoring
BE857981R (fr) 2,9-dioxatricyclo (4,3,1,0 3,7) decanes et procede pour leur preparation